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INTRODUCTION
Cancer is one of the most life‑threatening diseases, with more 
than 100 different types occurring due to some molecular changes 
within the cell. It is the third leading cause of death worldwide 
following cardiovascular and infectious diseases.[1] It is estimated 
that 12.5% of the population dies due to cancer (WHO, 2004). 
The disease is widely prevalent, and in the West, almost a third of 
the population develops cancer at some point of time during their 
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ABSTRACT
The present study was carried out to evaluate the anticancer, antioxidant, and possible anti‑inflammatory properties of diverse medicinal 
plants frequently used in Indian traditional medication. The selected botanicals such as Soymida fembrifuga (Roxb.) A. Juss. (Miliaceae), 
Tinospora cordifolia (Willd.) Miers. (Menispermaceae), Lavandula bipinnata (L.) O. Ktze. (Lamiaceae), and Helicteres isora 
L. (Sterculiaceae) extracted in different solvents were evaluated for their in vitro anticancer and antioxidant activities. The results 
obtained indicate that H. isora has potent cytotoxic activity toward the selected cancer cells such as HeLa‑B75 (34.21 ± 0.24%), 
HL‑60 (30.25 ± 1.36%), HEP‑3B (25.36 ± 1.78%), and PN‑15 (29.21 ± 0.52%). Interestingly, the selected botanicals selectively 
inhibited cyclooxygenase‑2 (COX‑2) more than (COX‑1), which are the key enzymes implicated in inflammation. COX‑2 inhibition 
was observed to be in the range of 19.66‑49.52% as compared to COX‑1 inhibition (3.93‑19.61%). The results of the antioxidant study 
revealed that the selected plants were found to be effective 1,1‑diphenyl‑2‑picrylhydrazyl (DPPH), hydroxyl (OH), and superoxide 
radical (SOR) scavenging agents. High‑performance thin layer chromatography (HPTLC) fingerprint of flavonoids was used as a 
measure of quality control of the selected plant samples. The results of the present findings strengthen the potential of the selected 
plants as a resource for the discovery of novel anticancer, anti‑inflammatory, and antioxidant agents.
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life. Although the mortality due to cancer is high, many advances 
have been made both in terms of treatment and understanding the 
biology of the disease at the molecular level.[2]
Breast cancer is the most common form of cancer in women. 
The incidence of breast cancer is the highest in Pakistan among the 
South‑Central Asian countries. It is the most frequent malignancy 
in women and accounts for 38.5% of all female cancers. About 
half (43.7%) of all breast cancers are detected in an advanced 
stage.[3] Colon cancer is the second most common cause of cancer 
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deaths in the US. Prostate cancer is the most frequently diagnosed 
cancer among men in the US, and ranks second to skin cancer, 
with an estimated 180,000 new cases and 37,000 deaths expected 
to occur by the American Cancer Society each year.[4]
Moreover, it is increasingly being realized that many of today’s 
diseases are due to the “oxidative stress” that results from an im‑
balance between the formation and neutralization of prooxidants. 
Oxidative stress is initiated by free radicals, which seek stability 
through electron pairing with biological macromolecules such 
as proteins, lipids, and DNA in healthy human cells and cause 
protein and DNA damage along with lipid peroxidation. These 
changes contribute to cancer, atherosclerosis, cardiovascular dis‑
eases, aging, and inflammatory diseases.[5,6] All cells are exposed 
to oxidative stress, and thus, oxidation and free radicals may be 
important in carcinogenesis at multiple tumor sites.
The enzymes cyclooxygenase‑1 and ‑2 (COX‑1 and ‑2) are the 
key enzymes involved in recruiting inflammation. Nevertheless, 
the proinflammatory cytokines play a crucial role in the initiation 
and progression of various cancers.[7] Besides the key role of COX 
in the initiation and progression of inflammation, overexpression 
of COX has been considered as one of the culprits in the formation 
of carcinogenic state in the body.[8] It is this molecular attribute of 
the COX upregulation that has made it an attractive target for the 
design and development of anticancer agents also. Free radical 
induced oxidative stress and its relevance with inflammation and 
carcinogenesis is well established.[9] Therefore, inflammation, free 
radicals, and carcinogenesis are closely related with one another. 
The drug candidates having anti‑inflammatory and free radical 
scavenging activities are more appreciated as anticancer agents.
Due to lack of effective drugs, cost of chemotherapeutic agents, 
and the side effects of anticancer drugs, cancer can be a cause of 
death. Therefore, efforts are still being made to search for effective 
naturally occurring anticarcinogens that would prevent, slow, or 
reverse cancer development. Medicinal plants have a special place 
in the management of cancer. It is estimated that plant‑derived 
compounds in one or the other way constitute more than 50% of 
anticancer agents.[10,11] Numerous cancer research studies have 
been conducted using traditional medicinal plants in an effort to 
discover new therapeutic agents that lack the toxic side effects 
associated with the present chemotherapeutic agents. Taking into 
consideration the above facts, an attempt has been made to evaluate 
the anticancer, anti‑inflammatory, and antioxidant activities of se‑
lective medicinal plants used in Indian traditional medicine system.
MATERIALS AND METHODS
Materials
3‑(4,5‑Dimethylthiazol‑2‑yl)‑2,5‑diphenyltetrazolium bro‑
mide (MTT) and 1,1‑diphenyl‑2‑picrylhydrazyl (DPPH) were 
purchased from Sigma‑Aldrich Co. (St Louis, MO, USA). The 
COX assay was performed by using colorimetric COX (ovine) 
inhibitor screening assay kit (catalog no. 760111; Cayman Chemi‑
cal Company, USA). 1,10‑Phenanthroline, phenazine methosul‑
fate (PMS), and nitroblue tetrazolium (NBT) were obtained from 
SD Fine Chem. (Mumbai, India). Nicotinamide adenine dinucleo‑
tide (NADH) was purchased from Spectrochem, Pvt Ltd (Mumbai, 
India). All other chemicals and reagents used were of AR grade 
and were obtained from commercial sources.
Collection, identification, and authentication of the selected 
medicinal plants
The selected plants, Soymida fembrifuga (Roxb.) A. 
Juss. (SRTH‑08), Tinospora cordifolia (Willd.) Miers. (SRTH‑54), 
Lavandula bipinnata (L.) O. Ktze. (SRTH‑24), and Helicteres isora 
L. (SRTH‑61), were collected from the nearby regions of Nanded 
district (Maharashtra) during September 2009. The plants were 
identified and authenticated by RNG, Head, Department of Botany, 
School of Life Sciences, Swami Ramanand Teerth Marathwada 
University, Nanded, Maharashtra, India.[12] Voucher specimens of 
the collected plants were deposited in the herbarium center of the 
host institute. The shade‑dried and powdered plant samples were 
preserved for further experiments.
Sequential extraction of the plant samples
The shade‑dried, powdered plant samples (10 g) were sequen‑
tially extracted in hexane, ethanol, and water as per their boiling 
points which are (69°C), (79°C), and (100°C), respectively, up to 
8 h using Soxhlet’s apparatus. The extracted samples were evapo‑
rated under reduced pressure at room temperature. The yield of the 
individual plant extract was measured and the dried extracts were 
preserved at 4°C in a refrigerator for further analysis.
HPTLC analysis
High‑performance thin layer chromatography (HPTLC) analy‑
sis was performed using the instrument from CAMAG (Germany). 
Thin layer chromatography (TLC) plates (silica gel >60 F254, 
20 cm × 10 cm; Merck) were prewashed with methanol. The plates 
were activated in an oven at 100°C for 10 min. Ten microliters of 
individual plant extracts (1 mg/ml) was spotted onto the precoated 
plates using Linomat 5 application system. Rutin hydrate (50, 100, 
200 μg/ml) was used as the marker flavonoid. The flavonoids were 
separated using ethyl acetate: Formic acid: Glacial acetic acid: 
Water (100:11:11:27) as the mobile phase. Natural product (NP) 
reagent was used as the flavonoid derivatizing agent, and the spots 
developed were visualized under CAMAG UV cabinet (366 nm) 
and digitized using CAMAG photodocumentation system.
Cell lines and culturing
Human cancer cell lines HeLa‑B75, HL‑60, HEP‑3B, PN‑15, 
and normal liver cell lines were obtained from National Center for 
Cell Sciences, Pune, Maharashtra. >All cell lines were propagated 
in Minimum Essential Medium (Eagle) with 2 mM l‑glutamine 
and Earle’s BSS (Balanced Salt Solution) adjusted to contain 
1.5 g/L sodium bicarbonate, 0.1 mM non‑essential amino acids, 
1 mM sodium pyruvate 90%, and 10% fetal calf serum. All cell 
lines were grown in a humidified incubator at 37°C.
MTT cytotoxicity assay for in vitro anticancer study
The cytotoxicity assay was performed according to the micro‑
culture MTT method with slight modifications.[13] The cells were 
harvested (1.5 × 104 cells/well) and inoculated in 96‑well microtiter 
plates. They were washed with phosphate‑buffered saline (PBS) 
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and the cultured cells were then inoculated with and without the 
extract (1 mg/ml). After 72 h of incubation, the medium was aspi‑
rated. Ten microliters of MTT solution (5 mg/ml in PBS, pH 7.2) 
was added to each well and the plates were incubated for 4 h at 37°C. 
After incubation, 100 μl of dimethyl sulfoxide (DMSO) was added 
to the wells followed by gentle shaking to solubilize the formazan 
dye for 15 min. Absorbance was read at 540 nm and the surviving 
cell fraction was calculated. Suramin (100 μM) was used as the refer‑
ence standard for anticancer activity, and H2O2 (1 mM) was used as 
the cytotoxic agent against normal liver cell lines. The inhibition of 
cell viability and COX was calculated using the formula:
Inhibitionactivity
T
C
(%) = − ×1 100
Where T= Absorbance of the test sample
C= Absorbance of the control sample
COX inhibition assay
The assay was performed using colorimetric COX (ovine) 
inhibitor screening assay kit.[14] Briefly, the reaction mixture con‑
tained 150 μl of assay buffer, 10 μl of heme, 10 μl of enzyme (ei‑
ther COX‑1 or COX‑2), and 10 μl of the plant sample (1 mg/ml). 
The assay utilizes the peroxidase component of COX. The per‑
oxidase activity was assayed colorimetrically by monitoring the 
appearance of oxidized N, N, N′, N′‑tetramethyl‑p‑phenylenediam
ine (TMPD) at 590 nm. Aspirin (acetylsalicylic acid, 1 mM) was 
used as the reference anti‑inflammatory compound.
Antioxidant study
DPPH radical scavenging assay
DPPH radical scavenging assay was carried out as per the 
method reported earlier, with slight modifications.[15,16] Briefly, 
1 ml of the test solution (individual plant extracts) was added to 
an equal quantity of 0.1 mM solution of DPPH in ethanol. After 
20 min of incubation at room temperature, the DPPH reduction 
was measured by reading the absorbance at 517 nm. Ascorbic 
acid (1 mM) was used as the reference compound.
Hydroxyl (OH) radical scavenging assay
The OH radical scavenging activity was determined using 
Fenton reaction.[17] The reaction mixture contained 60 μl of 
FeCl
2 
(1 mM), 90 μl of 1,10‑phenanthroline (1 mM), 2.4 ml of 
phosphate buffer (0.2 M, pH 7.8), 150 μl of H2O2 (0.17 M), and 
1.5 ml of individual plant extracts (1 mg/ml). The reaction was 
started by adding H2O2. After 5 min incubation at room tempera‑
ture, the absorbance was recorded at 560 nm. Ascorbic acid (1 mM) 
was used as the reference compound.
Superoxide radical scavenging assay
The superoxide anion scavenging assay was performed by the 
method reported earlier.[18] Superoxide anion radicals were gener‑
ated in a non‑enzymatic PMS–NADH system through the reaction 
of PMS, NADH, and oxygen. It was assayed by the reduction 
of NBT. In this experiment, superoxide anion was generated in 
3 ml of Tris HCl buffer (100 mM, pH 7.4) containing 0.75 ml of 
NBT (300 μM), 0.75 ml of NADH (936 μM), and 0.3 ml of the plant 
sample (1 mg/ml). The reaction was initiated by adding 0.75 ml of 
PMS (120 μM) to the mixture. After 5 min of incubation at room 
temperature, the absorbance at 560 nm was measured in a spectropho‑
tometer. Ascorbic acid (1 mM) was used as the reference compound.
RESULTS
Sequential extraction and HPTLC profiling
The powdered plant samples were extracted sequentially in 
hexane, ethanol, and water. HPTLC fingerprint of the derivatized 
flavonoids is shown in Figure 1. The plants were found to contain 
diverse flavonoids. However, none of the plants showed the pres‑
ence of rutin (used as marker flavonoid).
Anticancer activity of the selected medicinal plants
The results of cytotoxicity of the selected plant samples (ethanol 
extract) against the selected cancer cells are summarized in Table 1. 
It was observed that the ethanol phytofraction (1 mg/ml) of all the 
tested plants showed promising anticancer activity toward the se‑
lected cancer cell lines. L. bipinnata possessed significant anticancer 
activity by inhibiting PN‑15 (35.21 ± 1.48%), while S. fembrifuga 
showed moderate inhibition toward PN‑15 (06.35 ± 0.35%). All the 
plants under investigation were found to possess moderate cytotoxic 
activity toward HeLa‑B75 and HL‑60 cell lines, showing the activity 
in the range of 12.14‑34.21%. The cytotoxic activity was compared 
with suramin (0.01 mM), which was used as the standard anticancer 
drug (HeLa‑B75, 91.55%; HL‑60, 72.51%; HEP‑3B, 92.43%; and 
PN‑15, 77.38%). None of the plant samples showed cytotoxicity to‑
ward normal “Chang liver” cells, except the standard H2O2 (3.13%).
COX inhibitory potential of the selected medicinal plants
The results of COX inhibitory activity of the ethanolic fraction of 
the selected medicinal plants are shown in Figure 2. It is interesting 
to note that all the plant samples preferentially inhibited COX‑2 rath‑
er than COX‑1. L. bipinnata showed the maximum activity by inhib‑
iting COX‑2 (50.43 ± 0.39%) more than COX‑1 (18.63 ± 0.31%), 
Table 1. Cytotoxic effect of selected medicinal plant extracts (1 mg/ml) 
on different cancer cell lines and normal chang liver cells
Name of 
the plants
Cytotoxicity (%)
HeLa‑B75 HL‑60 HEP‑3B PN‑15 Chang 
liver cells
Soymida 
fembrifuga
26.32±0.54 12.14±1.23 10.35±1.26 06.35±0.35 −2.72±0.48
Tinospora 
cordifolia
28.21±1.95 21.35±0.26 34.21±0.25 24.21±0.27 −3.38±0.65
Lavandula 
bipinnata
18.65±0.47 34.14±1.69 24.69±0.36 35.21±1.48 −4.37±0.46
Helicteres 
isora
34.21±0.24 30.25±1.36 25.36±1.78 29.21±0.52 −3.72±0.65
Suramin 
(0.01 mM)
91.55±1.5 72.51±1.22 92.43±0.78 77.38±0.98 ND
H2O2 
(1 mM)
ND ND ND ND 3.13±0.50
Results presented here are the mean values from three independent 
experiments±S.D., ND: Not determined; NR: No reaction under 
experimental condition
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while all other plant samples inhibited COX‑1 and COX‑2 in the 
range of 03.93–23.53% and 19.66‑50.43%, respectively. Aspi‑
rin (COX‑1, 08.83 ± 0.37% and COX‑2, 08.83 ± 0.37%) was used 
as the standard anti‑inflammatory agent.
Antioxidant study
DPPH radical scavenging activity
The DPPH radical scavenging assay is used for preliminary 
screening of the plant extracts for their antioxidant activity. The 
proton radical scavenging action is known to be an important mech‑
anism of antioxidants. The results of this assay are summarized in 
Table 2. Overall, it was observed that the ethanolic fraction of all 
the selected plants was more potent in stabilizing DPPH radicals. 
Moreover, the ethanol extract of S. fembrifuga (71.43 ± 0.42%) 
possessed the highest DPPH radical scavenging ability, while for the 
rest of the plants, it was found to be in the range of 06.25‑66.67%, 
as compared to ascorbic acid (82.54 ± 0.02%).
OH radical scavenging activity
The OH radicals are the most hyperreactive amongst the rela‑
tive oxygen species and affect every type of molecule found in 
the living system. Physiologically important biomolecules such as 
sugar, amino acids, phospholipids, DNA bases, and organic acids 
may undergo reaction with OH radicals and may change the normal 
physiological function of cells. The OH radical scavenging activity 
of the selected medicinal plants is shown in Table 2. The water and 
ethanol extracts showed moderate OH radical scavenging activity 
in the range of 03.85‑17.31%, but not the hexane extract of the 
individual plant samples. Ascorbic acid (02.82 ± 0.02%) was used 
as the reference compound.
SO radical scavenging activity
The results of the SO radical scavenging activity of the selected 
medicinal plants are shown in Table 2. Water extract of all the 
selected plants was found to be an excellent SO radical scavenger, 
showing the activity in the range of 60.00‑71.22%. However, 
S. fembrifuga extracts showed promising SO radical scavenging 
activity in the order hexane, ethanol, and water (18.46, 59.03, and 
71.22%, respectively). A poor activity was observed in the hexane 
extract of T. cordifolia (08.34%).
DISCUSSION
Over the past decade, herbal medicines have been appreciated 
and accepted all over the world and they have made an impact 
on both global health and international trade. Hence, medicinal 
plants continue to play an important role in the healthcare system 
of a majority of the world’s population.[19] Traditional medicine is 
widely used in India. Even in the US, the use of plants and phyto‑
medicines has increased dramatically in the last two decades, and 
as a result, a National Centre for Complementary and Alternative 
Medicine has been established there. The herbal products have 
been classified under “dietary supplements” and are included with 
vitamins, minerals, amino acids and other products intended to 
supplement the diet.[20] In fact, there are several medicinal plants 
all over the world, including India, which are being used tradition‑
Figure 1. HPTLC profile of the selected medicinal plant extracts. Track No. 
1, rutin (50 µg); 2, rutin (100 µg); 3, rutin (200 µg); 4, Tinospora cordifolia; 
5, Lavandula bipinnata, 6, Helicteres isora; 7, Soymida fembrifuga
Figure 2. Inhibition of COX‑1 and COX‑2 by the selected medicinal 
plants. Data are shown as mean ± SD of three similar experiments
Table 2. Antioxidant activity of the selected medicinal plants
Name of 
the plant
Plant 
extracts
% radical scavenging activity
DPPH OH SOR
Soymida fembrifuga (W) 18.75±0.21 09.62±0.74 71.22±0.74
(E) 71.43±0.42 05.77±0.45 59.03±0.52
(H) 33.34±0.14 NR 18.46±0.19
Tinospora cordifolia (W) NR 17.31±0.42 62.44±0.45
(E) 28.58±0.13 05.77±0.26 NR
(H) NR NR 08.34±0.32
Lavandula bipinnata (W) 06.25±0.47 09.62±0.17 60.00±0.56
(E) 50.00±0.49 03.85±0.54 NR
(H) 33.34±0.26 NR NR
Helicteres isora (W) 62.50±0.54 13.46±0.56 70.74±0.55
(E) 35.72±0.23 NR NR
(H) 66.67±0.17 NR NR
AA (E) 82.54±0.02 02.82±0.02 51.24±0.02
Results presented here are the mean value of n=3±SD. NR: No reaction under 
experimental condition; W: Water; E: Ethanol; H: Hexane; AA: Ascorbic acid
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ally for the prevention and treatment of cancer. However, only a 
few medicinal plants have attracted the interest of scientists to 
investigate the remedy for neoplasm (tumor or cancer).
The plants consist of various phytochemicals which dissolve 
in specific solvents. According to this, the polar (ethanol, water) 
and nonpolar (hexane) solvents were selected for the extraction 
purpose. While describing the mechanism of anticancer, anti‑in‑
flammatory, and antioxidant activities of the medicinal plants, 
various phytochemicals seem to be associated with these activities. 
In particular, the phytochemicals such as vitamins (A, C, E, K), 
carotenoids, terpenoids, flavonoids, polyphenols, alkaloids, tan‑
nins, saponins, pigments, enzymes, and minerals have been found 
to elicit antioxidant activities.[21,22] With regard to the management 
of cancers, ellagic acid and a whole range of flavonoids, carot‑
enoids, and terpenoids present in Fragaria vesca (strawberries) 
and Rubus idaeus (raspberries) have been reported to be respon‑
sible for the antioxidant activity. These chemicals block various 
hormonal actions and metabolic pathways that are associated 
with the development of cancer.[23,24] A whole variety of phenolic 
compounds, in addition to flavonoids, are widely distributed in 
grains, fruits, vegetables, and herbs. Phenolic compounds such as 
caffeic and ferulic acids, sesamol, and vanillin have been reported 
to exhibit antioxidant and anticarcinogenic activities and inhibit 
atherosclerosis.[25,26]
The severe side effects of the presently used nonsteroidal anti‑in‑
flammatory drugs (NSAIDs) have resulted in either withdrawal or 
replacement of these drugs (nimesulide, bromfenac, ibufenac, and 
benoxaprofen) from the pharmaceutical market. Selective COX‑2 
inhibitors were described to be very effective in the management 
of inflammatory disorders. However, nonselective COX‑1 inhibi‑
tion by these agents imposed restrictions on the usage of selective 
COX‑2 inhibitors on health grounds. In an attempt to discover 
novel anti‑inflammatory agents targeting COX, the drug candi‑
dates selectively inhibiting COX‑2 and skipping COX‑1 are more 
appreciated as safe anti‑inflammatory drugs.[27] It is interesting to 
note that the selected plants preferentially inhibited COX‑2 activity 
more than that of COX‑1. This finding indicates the significance of 
the selected plants as a potential resource for the discovery of novel 
leads for maneuvering them as effective and safe anti‑inflammatory/
anticancer agents.
CONCLUSION
It can be summarized that the plants selected in the present 
study having importance in traditional medicine can be consid‑
ered as a source for the isolation, identification, and develop‑
ment of novel and effective anticancer, anti‑inflammatory, and 
antioxidant agents. Nevertheless, the research data of the present 
findings may serve as a guideline for the standardization and 
validation of natural drugs containing the selected medicinal 
plants as ingredients.
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